A recent message on one of the e-mail bulletin boards sent by a college student read, “I believe that the AIDS virus was developed in government labs for the purpose of controlling black folks.” In September 1990, Essence, an African American magazine with a circulation of 900,000, had as a lead article “AIDS: Is It Genocide?” In 1991, the New York Times quoted Clarence Page, African American columnist and Pulitzer prize winner: “You could call conspiracy theories about AIDS and drugs fringe ideas, but they seem, to have a large following among the black intelligentsia. … [And] you find it at all levels.” In April 1992, Lorene Gary explained in Newsweek “Why it's not just paranoia.” In that same month, another New York Times article reported: “Bizarre as it may seem to most people, many black Americans believe that AIDS and the health measures used against it are part of a conspiracy to wipe out the black race.”4 In February 1992, Science quoted Peter Breggin, director of the Center for the Study of Psychiatry in Bethesda, Maryland, as saying that research on violence “cloaks the intention to identify problem black children and then … prescribe pacifying drugs.”
1. Bates, KG. AIDS: is it genocide? Essence 1990; 21(09): 77–116.
2. DeParle, J. For some blacks, social ills seem to follow white plans. New York Times 1991 08. 11: 5.
3. Cary, L. Why it's not just paranoia. Newsweek 1992 04. 6: 23.
4. Anonymous. The AIDS ‘plot’ against blacks. New York Times 1992 05 12: 22.
5. Stone, R. HHS ‘violence initiative’ caught in crossfire. Science 1992; 258: 212.
6. Savitt, TL. Medicine and Slavery: The Diseases and Health Care of Blacks in Antebellum Virginia. Chicago: University of Illinois Press, 1978.
7. Abbot, WO. The problem of the professional guinea pig. Proceedings of the Charaka Club 1941; 10: 249–60.
8. Kiple, KF, King, VH. Another Dimension to the Black Diaspora: Diet, Disease, and Racism. Cambridge, England: Cambridge University Press, 1981: 163–74.
9. Turner, PA. I Heard It through the Grapevine: Rumor in African-American Culture. Berkeley: University of California Press, 1993.
10. Fry, GM. Night Riders in Black Folk History. Knoxville: University of Tennessee Press, 1975.
11. Jones, JH. Bad Blood: The Tuskegee Syphilis Experiment: A Tragedy of Race and Medicine. New York: The Free Press, 1981.
12. Dalton, HL. AIDS in blackface. Daedalus 1989; 118(3): 220.
13. Savitt, TL, Goldberg, MF. Herrick's 1919 case report of sickle cell anemia: the rest of the story. Journal of the American Medical Association 1989; 261: 266–71.
14. Culliton, BJ. Sickle cell anemia: national program raises problems as well as hopes. Science 1972; 98: 283–6.
15. Scott, R. Health care priority and sickle cell anemia. Journal of the American Medical Association 1970; 214: 731–4.
16. King, PA. The past as prologue: race, class, and gene discrimination. In: Annas, GJ, Elias, S, eds. Gene Mapping: Using Law and Ethics as Guides. New York: Oxford University Press, 1992: 94–111.
17. Bowman, J. Ethical and social issues in screening for genetic disease. New England Journal of Medicine 1972; 287: 204–5.
18. Whitten, C. Sickle-cell programming-an imperiled promise. New England Journal of Medicine 1973; 288: 318–9.
19. Rutkow, IM, Upton, JM. Some negative aspects of state health departments' policies related to screening for sickle cell anemia. American Journal of Public Health 1974; 64: 217–21.
20. Jones, S, Binder, R, Donowho, E. Sudden death in sickle-cell trait. New England Journal of Medicine 1970; 282: 323–5.
21. Letters to the Editor. Sickle cell trait. New England Journal of Medicine 1970; 282: 1157–8.
22. Bowman, J. Ethical, legal, and humanistic implications of sickle cell programs. Inserm 1975; 44: 353–78.
23. Murray, RF. Public health perspectives on screening and problems in counseling in sickle cell anemia. In: Cohen, B, Lilienfield, A, Glass, B, eds. Genetic Issues in Public Health and Medicine. Springfield, Illinois: Charles C Thomas, 1978: 264–79.
24. Grossman, LK, Holtzman, N, Charney, E, Schwartz, AD. Neonatal screening and genetic counseling for sickle cell trait. American Journal of Disabled Child 1985; 139: 241–4.
25. Mass, B. Population Target: The Political Economy of Population Control in Latin America. Toronto: Women's Press, 1976.
26. Gordon, L. Woman's Body, Woman's Right: Birth Control in America. 2nd ed.New York: Penguin, 1975.
27. Rodriguez-Trias, H. Sterilization abuse. In: Hubbard, R, Henifin, MS, Fried, B, eds. Biological Woman - The Convenient Myth: A Collection of Feminist Essays and a Comprehensive Bibliography. Cambridge, Massachusetts: Schenkman, 1982: 147–60.
28. Petchesky, RP. Reproduction, ethics, and public policy: the federal sterilization regulations. Hastings Center Report 1979; 5: 29–41.
29. Aptheker, H. Sterilization, experimentation and imperialism. Political Affairs 1974; 53: 37–48.
30. Reilly, PR. The Surgical Solution: A History of Involuntary Sterilization in the United States. Baltimore, Maryland: Johns Hopkins University Press, 1991.
31. Thomas, SB, Quinn, SC. The AIDS epidemic and the African-American community: toward a new ethical framework for service delivery. In: Dula, A, Goering, S, eds. “It Just Ain't Fair!” The Ethics of Health Care for African Americans. Westport, Connecticut: Greenwood (in press).
32. Horgan, J. Eugenics revisited. Scientific American 1993; 268: 122–31.
33. Bass, A. Controversy places research in peril. The Boston Globe 1993 02. 2: 37.
34. Saltus, R. Evidence that genes play a role in violence is weak. The Boston Globe 1993 02. 2: 37.
35. Marshall, E. NIH told to reconsider crime meeting. Science 1993; 262: 24.
36. Morell, V. Evidence found for a possible “aggression gene.” Science 1993; 260: 1722–3.
37. Centers for Disease Control. Infant mortality - United States, 1991. Morbidity and Mortality Weekly Report 1993; 42(48): 926–30.
38. Centers for Disease Control. Surveillance for diabetes mellitus-United States, 1980–1989. Morbidity and Mortality Weekly Report 1993; 42(SS–2): 1–20.
39. Centers for Disease Control. Tuberculosis morbidity - United States, 1992. Morbidity and Mortality Weekly Report 1993; 42(36): 696.
40. Baquet, CR, Gibbs, T. Cancer and black Americans. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 106–2.
41. Centers for Disease Control. Update: mortality attributable to HIV infection/AIDS among persons aged 25–44 years -United States, 1990 and 1991. Morbidity and Mortality Weekly Report 1993; 42(25):481–6.
42. Hildreth, CJ, Saunders, E. Heart disease, stroke, and hypertension in blacks. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 90–105.
43. Hale, CB. A demographic profile of African Americans. In: Braithwaite, RL, Taylor, SE, eds. Health Issues in the Black Community. San Francisco: Jossey-Bass, 1992: 6–19.
44. Escarce, JJ, Epstein, KR, Colby, DC, Schwartz, JS. Racial differences in the elderly's use of medical procedures and diagnostic tests. American Journal of Public Health 1993; 83(7): 948–54.
45. Whittle, J, Conigliaro, J, Good, CB, Lofgren, RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. New England Journal of Medicine 1993; 329: 621–7.
46. Gaston, RS, Ayres, I, Dooley, LG, Diethelm, AG. Racial equality in renal transplantation: the disparate impact of HLA-based allocation. Journal of the American Medical Association 1993; 270: 1353.
47. Caralis, PV, Davis, B, Wright, K, Marcial, E. The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. The Journal of Clinical Ethics 1993; 4(2): 155–6.
48. Pappas, G, Queen, S, Hadden, W, Fisher, G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. New England Journal of Medicine 1993; 329: 103–9.
49. Anderson, W. The New York needle trial: the politics of public health in the age of AIDS. American Journal of Public Health 1991; 81: 1512.
50. Gemson, DH, Elinson, J, Messeri, P. Differences in physician prevention practices for white and minority patients. Journal of Community Health 1988; 13: 53–64.
51. Ayanian, JZ. Heart disease in black and white. New England Journal of Medicine 1993; 329: 656–7.
52. Svensson, CK. Representation of American blacks in clinical trials of new drugs. Journal of the American Medical Association 1989; 261: 263–5.
53. El-Sadr, W, Capps, L. The challenge of minority recruitment in clinical trials for AIDS. Journal of the American Medical Association 1992; 267: 954–7.
54. Morsy, MA, Mitani, K, Clemens, P, Caskey, T. Progress toward human gene therapy. Journal of the American Medical Association 1993; 270: 2338–45.
55. Annas, GJ. Privacy rules for DNA databanks: protecting coded “future diaries.” Journal of the American Medical Association 1993; 270: 2346–50.
56. Bowman, J. Genetic screening: toward a new eugenic. In: Dula, A, Goering, S, eds. “It Just Ain't Fair!” The Ethics of Health Care for African Americans. Westport, Connecticut: Greenwood (in press).
57. Rosenberg, ML, O'Carroll, PW, Powell, KE. Let's be clear: violence is a public health problem. Journal of the American Medical Association 1992; 267: 3073.
58. Mason, JO, McGinnis, JM. “Healthy People 2000”: an overview of the national health promotion and disease prevention objectives. Public Health Reports 1990; 105: 441–6.
59. Centers for Disease Control. Use of race and ethnicity in public health surveillance: summary of the CDC/ATSDR Workshop. Morbidity and Mortality Weekly Report 1993; 42(RR–10): 1–17.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 24th June 2018. This data will be updated every 24 hours.